Next Article in Journal
Betulin-3,28-diphosphate as a Component of Combination Cytostatic Drugs for the Treatment of Ehrlich Ascites Carcinoma In Vitro and In Vivo Experiments
Previous Article in Journal
Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
Article Menu

Export Article

Open AccessArticle
Sci. Pharm. 2018, 86(2), 16; https://doi.org/10.3390/scipharm86020016

Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier

1
Nanotechnology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, 6135715794 Ahvaz, Iran
2
Department of Pharmaceutics, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, 6135715794 Ahvaz, Iran
3
Research Center of Thalassemia & Hemoglobinopathy, Ahvaz Jundishapur University of Medical Ciences, 6135715794 Ahvaz, Iran
*
Author to whom correspondence should be addressed.
Received: 1 February 2018 / Revised: 31 March 2018 / Accepted: 9 April 2018 / Published: 20 April 2018
Full-Text   |   PDF [9168 KB, uploaded 3 May 2018]   |  

Abstract

One drawback of traditional forms of medical ocular dosage is drug dilution by tear; moreover, drugs are rapidly drained away from pre-corneal cavity by tear flow and lacrimo-nasal drainage. Prolonging contact time with different strategies and mucoadhesive vehicles will help to continuously deliver drugs to the eyes. For this study, we prepared and evaluated the effects of a nanostructure lipid carrier (NLC) on propranolol hydrochloride as a hydrophilic drug model for rabbit corneal permeation. Propranolol hydrochloride NLC was prepared using cold homogenization. The lipid was melted, then the drug and surfactant were dispersed and stirred into the melted lipid. This fused lipid phase was scattered in aqueous solution containing the cosurfactant at 4 °C and then homogenized. We evaluated particle size, drug loading, drug release, and NLC permeability through rabbit cornea as well as the formula’s effect on the cornea. Our results show that drug loading efficiency depended on the surfactant/lipid ratio (S/L) and the percentages of liquid lipid and Transcutol (Gattefosse, Saint-Priest, France) (as solubilizer). Drug release data were evaluated with the Higuchi model and a significant correlation was shown between the S/L ratio and the amount of drug released after 4 and 48 h. NLC formulations improved propranolol hydrochloride permeation. We conclude that the effect of the NLC formulations was due to mucoadhesive and film forming properties. View Full-Text
Keywords: ocular; drug delivery; permeability; propranolol hydrochloride; nanostructured lipid carrier ocular; drug delivery; permeability; propranolol hydrochloride; nanostructured lipid carrier
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Sharif Makhmal Zadeh, B.; Niro, H.; Rahim, F.; Esfahani, G. Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier. Sci. Pharm. 2018, 86, 16.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top